Structure

Physi-Chem Properties

Molecular Weight:  494.19
Volume:  508.495
LogP:  6.088
LogD:  2.999
LogS:  -3.61
# Rotatable Bonds:  9
TPSA:  112.27
# H-Bond Aceptor:  8
# H-Bond Donor:  1
# Rings:  3
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.193
Synthetic Accessibility Score:  3.333
Fsp3:  0.321
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -4.885
MDCK Permeability:  2.060472070297692e-05
Pgp-inhibitor:  0.989
Pgp-substrate:  0.069
Human Intestinal Absorption (HIA):  0.787
20% Bioavailability (F20%):  0.075
30% Bioavailability (F30%):  0.036

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.02
Plasma Protein Binding (PPB):  90.81652069091797%
Volume Distribution (VD):  1.229
Pgp-substrate:  11.21955394744873%

ADMET: Metabolism

CYP1A2-inhibitor:  0.174
CYP1A2-substrate:  0.32
CYP2C19-inhibitor:  0.628
CYP2C19-substrate:  0.269
CYP2C9-inhibitor:  0.894
CYP2C9-substrate:  0.895
CYP2D6-inhibitor:  0.007
CYP2D6-substrate:  0.246
CYP3A4-inhibitor:  0.236
CYP3A4-substrate:  0.164

ADMET: Excretion

Clearance (CL):  1.26
Half-life (T1/2):  0.186

ADMET: Toxicity

hERG Blockers:  0.002
Human Hepatotoxicity (H-HT):  0.05
Drug-inuced Liver Injury (DILI):  0.658
AMES Toxicity:  0.262
Rat Oral Acute Toxicity:  0.842
Maximum Recommended Daily Dose:  0.275
Skin Sensitization:  0.932
Carcinogencity:  0.369
Eye Corrosion:  0.004
Eye Irritation:  0.275
Respiratory Toxicity:  0.395

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC474350

Natural Product ID:  NPC474350
Common Name*:   Di-O-Acetylmangostin
IUPAC Name:   [6-acetyloxy-1-hydroxy-7-methoxy-2,8-bis(3-methylbut-2-enyl)-9-oxoxanthen-3-yl] acetate
Synonyms:   Di-O-Acetylmangostin
Standard InCHIKey:  WBVGQHDFFNOEEI-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C28H30O8/c1-14(2)8-10-18-20(34-16(5)29)12-22-25(26(18)31)27(32)24-19(11-9-15(3)4)28(33-7)23(35-17(6)30)13-21(24)36-22/h8-9,12-13,31H,10-11H2,1-7H3
SMILES:  COc1c(OC(=O)C)cc2c(c1CC=C(C)C)c(=O)c1c(o2)cc(c(c1O)CC=C(C)C)OC(=O)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL465553
PubChem CID:   44566652
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones
                • [CHEMONTID:0003519] 8-prenylated xanthones

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[18464091]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[18558747]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[19299148]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota stem bark Pangradin village, Jasinga, West Java, Indonesia 2005-AUG PMID[19839614]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[20817450]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. pericarp n.a. PMID[24555285]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. PMID[24717154]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota fruit hulls Madras, Tamil Nadu, India 1993-MAR PMID[9213587]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota Fruit n.a. n.a. Database[FooDB]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota Leaf n.a. n.a. Database[FooDB]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. Database[FooDB]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[HerDing]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[TCMID]
NPO6249 Garcinia mangostana Species Clusiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT139 Cell Line HT-29 Homo sapiens ED50 = 1.0 uM PMID[570144]
NPT139 Cell Line HT-29 Homo sapiens IC50 = 1800.0 nM PMID[570144]
NPT397 Cell Line NCI-H460 Homo sapiens IC50 = 12490.0 nM PMID[570145]
NPT2297 Cell Line ASPC1 Homo sapiens IC50 = 14250.0 nM PMID[570145]
NPT82 Cell Line MDA-MB-231 Homo sapiens IC50 = 17450.0 nM PMID[570145]
NPT323 Cell Line SW-620 Homo sapiens IC50 = 22730.0 nM PMID[570145]
NPT2646 Organism Alternaria tenuis Alternaria tenuis Inhibition = 8.0 % PMID[570143]
NPT2646 Organism Alternaria tenuis Alternaria tenuis Inhibition = 6.0 % PMID[570143]
NPT2646 Organism Alternaria tenuis Alternaria tenuis Inhibition = -6.0 % PMID[570143]
NPT2647 Organism Drechslera Drechslera Inhibition = 11.0 % PMID[570143]
NPT2647 Organism Drechslera Drechslera Inhibition = 51.0 % PMID[570143]
NPT2647 Organism Drechslera Drechslera Inhibition = 14.0 % PMID[570143]
NPT2648 Organism Fusarium oxysporum f. sp. vasinfectum Fusarium oxysporum f. sp. vasinfectum Inhibition = 6.0 % PMID[570143]
NPT2648 Organism Fusarium oxysporum f. sp. vasinfectum Fusarium oxysporum f. sp. vasinfectum Inhibition = 5.0 % PMID[570143]
NPT2648 Organism Fusarium oxysporum f. sp. vasinfectum Fusarium oxysporum f. sp. vasinfectum Inhibition = 4.0 % PMID[570143]
NPT2648 Organism Fusarium oxysporum f. sp. vasinfectum Fusarium oxysporum f. sp. vasinfectum Inhibition = 3.0 % PMID[570143]
NPT721 Individual Protein Nuclear factor NF-kappa-B p65 subunit Homo sapiens IC50 > 10000.0 nM PMID[570144]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 15080.0 nM PMID[570145]
NPT35 Others n.a. Solubility = 122000.0 nM PMID[570145]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC474350 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9675 High Similarity NPC217677
0.9675 High Similarity NPC165977
0.9623 High Similarity NPC99613
0.9623 High Similarity NPC49487
0.9551 High Similarity NPC475886
0.9551 High Similarity NPC228785
0.9551 High Similarity NPC474287
0.9551 High Similarity NPC14353
0.9551 High Similarity NPC56085
0.9503 High Similarity NPC158226
0.9497 High Similarity NPC29160
0.9494 High Similarity NPC300984
0.949 High Similarity NPC474351
0.949 High Similarity NPC278052
0.949 High Similarity NPC475883
0.949 High Similarity NPC40491
0.949 High Similarity NPC474186
0.949 High Similarity NPC474187
0.949 High Similarity NPC61010
0.9487 High Similarity NPC100123
0.9441 High Similarity NPC124470
0.9441 High Similarity NPC109827
0.9437 High Similarity NPC234331
0.9434 High Similarity NPC267153
0.943 High Similarity NPC229632
0.943 High Similarity NPC93739
0.9427 High Similarity NPC320359
0.9423 High Similarity NPC300727
0.9423 High Similarity NPC241904
0.9387 High Similarity NPC289147
0.9379 High Similarity NPC163130
0.9379 High Similarity NPC165979
0.9375 High Similarity NPC20216
0.9371 High Similarity NPC236521
0.9371 High Similarity NPC152659
0.9371 High Similarity NPC156082
0.9371 High Similarity NPC284007
0.9371 High Similarity NPC220313
0.9371 High Similarity NPC7483
0.9371 High Similarity NPC248638
0.9371 High Similarity NPC197168
0.9371 High Similarity NPC236132
0.9367 High Similarity NPC66288
0.9367 High Similarity NPC303565
0.9363 High Similarity NPC476242
0.9359 High Similarity NPC274730
0.9359 High Similarity NPC54928
0.9359 High Similarity NPC142339
0.9333 High Similarity NPC113446
0.9321 High Similarity NPC20543
0.9321 High Similarity NPC17219
0.9321 High Similarity NPC246716
0.9321 High Similarity NPC239440
0.9313 High Similarity NPC472450
0.9313 High Similarity NPC275780
0.9313 High Similarity NPC25361
0.9313 High Similarity NPC326520
0.9313 High Similarity NPC8070
0.9313 High Similarity NPC112981
0.9313 High Similarity NPC239752
0.9308 High Similarity NPC52204
0.9308 High Similarity NPC108767
0.9308 High Similarity NPC25152
0.9299 High Similarity NPC36852
0.9299 High Similarity NPC236796
0.9299 High Similarity NPC78225
0.9299 High Similarity NPC262286
0.9295 High Similarity NPC471800
0.9268 High Similarity NPC139350
0.9259 High Similarity NPC26568
0.9255 High Similarity NPC170245
0.9255 High Similarity NPC472452
0.9255 High Similarity NPC39091
0.925 High Similarity NPC23298
0.925 High Similarity NPC270837
0.925 High Similarity NPC41301
0.925 High Similarity NPC189473
0.9245 High Similarity NPC266314
0.9245 High Similarity NPC32694
0.9241 High Similarity NPC238381
0.9241 High Similarity NPC83763
0.9241 High Similarity NPC168616
0.9236 High Similarity NPC138243
0.9236 High Similarity NPC191146
0.9236 High Similarity NPC68093
0.9231 High Similarity NPC475895
0.9231 High Similarity NPC89474
0.9226 High Similarity NPC117579
0.9226 High Similarity NPC474663
0.9207 High Similarity NPC181523
0.9202 High Similarity NPC1827
0.9202 High Similarity NPC10576
0.9198 High Similarity NPC117854
0.9198 High Similarity NPC272485
0.9198 High Similarity NPC477154
0.9198 High Similarity NPC6588
0.9198 High Similarity NPC292788
0.9187 High Similarity NPC294965
0.9182 High Similarity NPC45146
0.9182 High Similarity NPC200746
0.9182 High Similarity NPC36217
0.9182 High Similarity NPC119224
0.9182 High Similarity NPC299436
0.9182 High Similarity NPC235018
0.9177 High Similarity NPC476981
0.9177 High Similarity NPC223787
0.9177 High Similarity NPC136674
0.9177 High Similarity NPC108456
0.9177 High Similarity NPC469584
0.9177 High Similarity NPC181960
0.9172 High Similarity NPC20541
0.9172 High Similarity NPC37392
0.9172 High Similarity NPC113906
0.9172 High Similarity NPC472909
0.9167 High Similarity NPC289968
0.9161 High Similarity NPC29056
0.9161 High Similarity NPC227122
0.9161 High Similarity NPC179183
0.9136 High Similarity NPC37870
0.9136 High Similarity NPC472449
0.913 High Similarity NPC146134
0.913 High Similarity NPC273959
0.913 High Similarity NPC475985
0.913 High Similarity NPC234004
0.9119 High Similarity NPC95936
0.9119 High Similarity NPC329091
0.9119 High Similarity NPC235448
0.9119 High Similarity NPC250214
0.9114 High Similarity NPC146211
0.9108 High Similarity NPC250822
0.9108 High Similarity NPC75279
0.9108 High Similarity NPC280937
0.9108 High Similarity NPC472915
0.9108 High Similarity NPC276409
0.9103 High Similarity NPC149614
0.9103 High Similarity NPC202157
0.9103 High Similarity NPC226973
0.9103 High Similarity NPC208043
0.9103 High Similarity NPC198615
0.9097 High Similarity NPC328119
0.9074 High Similarity NPC473286
0.9068 High Similarity NPC329760
0.9068 High Similarity NPC472448
0.9068 High Similarity NPC201800
0.9068 High Similarity NPC8300
0.9068 High Similarity NPC470694
0.9068 High Similarity NPC83922
0.9062 High Similarity NPC80375
0.9062 High Similarity NPC471973
0.9062 High Similarity NPC143050
0.9062 High Similarity NPC246478
0.9062 High Similarity NPC47623
0.9062 High Similarity NPC204290
0.9062 High Similarity NPC476980
0.9062 High Similarity NPC139036
0.9057 High Similarity NPC472911
0.9057 High Similarity NPC48208
0.9057 High Similarity NPC162869
0.9057 High Similarity NPC472913
0.9057 High Similarity NPC472914
0.9057 High Similarity NPC474208
0.9057 High Similarity NPC245758
0.9057 High Similarity NPC222814
0.9057 High Similarity NPC474836
0.9057 High Similarity NPC96167
0.9057 High Similarity NPC475267
0.9057 High Similarity NPC472910
0.9057 High Similarity NPC156057
0.9051 High Similarity NPC230149
0.9051 High Similarity NPC92659
0.9051 High Similarity NPC152951
0.9051 High Similarity NPC227325
0.9051 High Similarity NPC226025
0.9051 High Similarity NPC167815
0.9051 High Similarity NPC201136
0.9051 High Similarity NPC146165
0.9051 High Similarity NPC2476
0.9051 High Similarity NPC57674
0.9051 High Similarity NPC128863
0.9051 High Similarity NPC477503
0.9051 High Similarity NPC138360
0.9051 High Similarity NPC280339
0.9051 High Similarity NPC183597
0.9051 High Similarity NPC255807
0.9051 High Similarity NPC45849
0.9051 High Similarity NPC50715
0.9051 High Similarity NPC200761
0.9051 High Similarity NPC31018
0.9051 High Similarity NPC4455
0.9051 High Similarity NPC168247
0.9051 High Similarity NPC196439
0.9051 High Similarity NPC208197
0.9051 High Similarity NPC163780
0.9051 High Similarity NPC117992
0.9051 High Similarity NPC470327
0.9045 High Similarity NPC101996
0.9045 High Similarity NPC120537
0.9045 High Similarity NPC180234
0.9045 High Similarity NPC199100
0.9045 High Similarity NPC471982

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC474350 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9068 High Similarity NPD6232 Discontinued
0.9018 High Similarity NPD7473 Discontinued
0.8987 High Similarity NPD2801 Approved
0.8909 High Similarity NPD5844 Phase 1
0.8868 High Similarity NPD7819 Suspended
0.8868 High Similarity NPD2393 Clinical (unspecified phase)
0.8805 High Similarity NPD1934 Approved
0.875 High Similarity NPD1465 Phase 2
0.8712 High Similarity NPD5494 Approved
0.8696 High Similarity NPD3817 Phase 2
0.8642 High Similarity NPD4868 Clinical (unspecified phase)
0.8589 High Similarity NPD7075 Discontinued
0.8588 High Similarity NPD4338 Clinical (unspecified phase)
0.8503 High Similarity NPD6166 Phase 2
0.8503 High Similarity NPD6167 Clinical (unspecified phase)
0.8503 High Similarity NPD6168 Clinical (unspecified phase)
0.8481 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.8434 Intermediate Similarity NPD6959 Discontinued
0.8418 Intermediate Similarity NPD1511 Approved
0.8415 Intermediate Similarity NPD3882 Suspended
0.8412 Intermediate Similarity NPD7074 Phase 3
0.8405 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.8402 Intermediate Similarity NPD3818 Discontinued
0.8395 Intermediate Similarity NPD7411 Suspended
0.8365 Intermediate Similarity NPD2533 Approved
0.8365 Intermediate Similarity NPD2532 Approved
0.8365 Intermediate Similarity NPD2534 Approved
0.8353 Intermediate Similarity NPD7054 Approved
0.8333 Intermediate Similarity NPD4380 Phase 2
0.8333 Intermediate Similarity NPD970 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD1512 Approved
0.8304 Intermediate Similarity NPD7472 Approved
0.8272 Intermediate Similarity NPD3226 Approved
0.8253 Intermediate Similarity NPD3749 Approved
0.8242 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.8232 Intermediate Similarity NPD6801 Discontinued
0.8205 Intermediate Similarity NPD2935 Discontinued
0.8192 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.8176 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.8161 Intermediate Similarity NPD7808 Phase 3
0.8153 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.8153 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.815 Intermediate Similarity NPD6797 Phase 2
0.815 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.8144 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.8137 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD5402 Approved
0.8113 Intermediate Similarity NPD3750 Approved
0.8103 Intermediate Similarity NPD7251 Discontinued
0.8101 Intermediate Similarity NPD1549 Phase 2
0.8095 Intermediate Similarity NPD919 Approved
0.8075 Intermediate Similarity NPD6799 Approved
0.8038 Intermediate Similarity NPD2346 Discontinued
0.8035 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.8012 Intermediate Similarity NPD37 Approved
0.8 Intermediate Similarity NPD6559 Discontinued
0.8 Intermediate Similarity NPD6599 Discontinued
0.8 Intermediate Similarity NPD1247 Approved
0.8 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7988 Intermediate Similarity NPD6234 Discontinued
0.7976 Intermediate Similarity NPD4965 Approved
0.7976 Intermediate Similarity NPD4967 Phase 2
0.7976 Intermediate Similarity NPD4966 Approved
0.7976 Intermediate Similarity NPD7768 Phase 2
0.7949 Intermediate Similarity NPD447 Suspended
0.7937 Intermediate Similarity NPD2800 Approved
0.7927 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7911 Intermediate Similarity NPD1510 Phase 2
0.7907 Intermediate Similarity NPD3926 Phase 2
0.7895 Intermediate Similarity NPD7199 Phase 2
0.7892 Intermediate Similarity NPD7501 Clinical (unspecified phase)
0.7885 Intermediate Similarity NPD1240 Approved
0.7862 Intermediate Similarity NPD2796 Approved
0.7849 Intermediate Similarity NPD5710 Approved
0.7849 Intermediate Similarity NPD5711 Approved
0.7826 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7826 Intermediate Similarity NPD1243 Approved
0.7818 Intermediate Similarity NPD920 Approved
0.7803 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD3748 Approved
0.7799 Intermediate Similarity NPD1509 Clinical (unspecified phase)
0.7799 Intermediate Similarity NPD2799 Discontinued
0.7785 Intermediate Similarity NPD1607 Approved
0.7771 Intermediate Similarity NPD7228 Approved
0.7744 Intermediate Similarity NPD7390 Discontinued
0.774 Intermediate Similarity NPD5953 Discontinued
0.7722 Intermediate Similarity NPD230 Phase 1
0.7722 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7711 Intermediate Similarity NPD5403 Approved
0.7709 Intermediate Similarity NPD8313 Approved
0.7709 Intermediate Similarity NPD8312 Approved
0.7697 Intermediate Similarity NPD642 Clinical (unspecified phase)
0.7669 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7665 Intermediate Similarity NPD1653 Approved
0.7658 Intermediate Similarity NPD943 Approved
0.7643 Intermediate Similarity NPD2313 Discontinued
0.7643 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.764 Intermediate Similarity NPD6099 Approved
0.764 Intermediate Similarity NPD6100 Approved
0.764 Intermediate Similarity NPD1551 Phase 2
0.7636 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD7286 Phase 2
0.761 Intermediate Similarity NPD1933 Approved
0.759 Intermediate Similarity NPD5401 Approved
0.7582 Intermediate Similarity NPD8150 Discontinued
0.7579 Intermediate Similarity NPD7435 Discontinued
0.7577 Intermediate Similarity NPD7783 Phase 2
0.7577 Intermediate Similarity NPD7782 Clinical (unspecified phase)
0.7576 Intermediate Similarity NPD643 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD3751 Discontinued
0.7565 Intermediate Similarity NPD8151 Discontinued
0.7564 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7562 Intermediate Similarity NPD6651 Approved
0.7561 Intermediate Similarity NPD4628 Phase 3
0.7543 Intermediate Similarity NPD3787 Discontinued
0.7543 Intermediate Similarity NPD7229 Phase 3
0.7516 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7513 Intermediate Similarity NPD6782 Approved
0.7513 Intermediate Similarity NPD6777 Approved
0.7513 Intermediate Similarity NPD6779 Approved
0.7513 Intermediate Similarity NPD6778 Approved
0.7513 Intermediate Similarity NPD6776 Approved
0.7513 Intermediate Similarity NPD6780 Approved
0.7513 Intermediate Similarity NPD6781 Approved
0.7486 Intermediate Similarity NPD8434 Phase 2
0.7469 Intermediate Similarity NPD651 Clinical (unspecified phase)
0.7455 Intermediate Similarity NPD1878 Clinical (unspecified phase)
0.7438 Intermediate Similarity NPD1613 Approved
0.7438 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.7436 Intermediate Similarity NPD1203 Approved
0.7421 Intermediate Similarity NPD3268 Approved
0.7412 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.741 Intermediate Similarity NPD6190 Approved
0.7405 Intermediate Similarity NPD6832 Phase 2
0.7403 Intermediate Similarity NPD7240 Approved
0.7401 Intermediate Similarity NPD5242 Approved
0.7396 Intermediate Similarity NPD7696 Phase 3
0.7396 Intermediate Similarity NPD7698 Approved
0.7396 Intermediate Similarity NPD7697 Approved
0.7381 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7378 Intermediate Similarity NPD2344 Approved
0.7363 Intermediate Similarity NPD4419 Clinical (unspecified phase)
0.7358 Intermediate Similarity NPD7870 Phase 2
0.7358 Intermediate Similarity NPD4625 Phase 3
0.7358 Intermediate Similarity NPD7871 Phase 2
0.7347 Intermediate Similarity NPD7875 Clinical (unspecified phase)
0.7347 Intermediate Similarity NPD7874 Approved
0.7337 Intermediate Similarity NPD1940 Clinical (unspecified phase)
0.7329 Intermediate Similarity NPD4060 Phase 1
0.7326 Intermediate Similarity NPD7615 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD2797 Approved
0.7317 Intermediate Similarity NPD5405 Approved
0.7317 Intermediate Similarity NPD5404 Approved
0.7317 Intermediate Similarity NPD5406 Approved
0.7317 Intermediate Similarity NPD5408 Approved
0.7312 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.7312 Intermediate Similarity NPD4287 Approved
0.7312 Intermediate Similarity NPD1699 Clinical (unspecified phase)
0.7308 Intermediate Similarity NPD7685 Pre-registration
0.7299 Intermediate Similarity NPD5353 Approved
0.7288 Intermediate Similarity NPD8127 Discontinued
0.7284 Intermediate Similarity NPD1899 Clinical (unspecified phase)
0.7278 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7268 Intermediate Similarity NPD7549 Discontinued
0.7263 Intermediate Similarity NPD8090 Clinical (unspecified phase)
0.7254 Intermediate Similarity NPD6823 Phase 2
0.725 Intermediate Similarity NPD3027 Phase 3
0.7249 Intermediate Similarity NPD6534 Approved
0.7249 Intermediate Similarity NPD6535 Approved
0.7245 Intermediate Similarity NPD7701 Phase 2
0.7244 Intermediate Similarity NPD1608 Approved
0.7244 Intermediate Similarity NPD9717 Approved
0.7209 Intermediate Similarity NPD7458 Discontinued
0.7205 Intermediate Similarity NPD3764 Approved
0.7202 Intermediate Similarity NPD2309 Approved
0.72 Intermediate Similarity NPD4288 Approved
0.7188 Intermediate Similarity NPD4908 Phase 1
0.7179 Intermediate Similarity NPD422 Phase 1
0.7178 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7178 Intermediate Similarity NPD5124 Phase 1
0.7158 Intermediate Similarity NPD4360 Phase 2
0.7158 Intermediate Similarity NPD4363 Phase 3
0.7152 Intermediate Similarity NPD4308 Phase 3
0.7152 Intermediate Similarity NPD7033 Discontinued
0.7143 Intermediate Similarity NPD8455 Phase 2
0.7143 Intermediate Similarity NPD7003 Approved
0.7136 Intermediate Similarity NPD7801 Approved
0.7135 Intermediate Similarity NPD6273 Approved
0.7135 Intermediate Similarity NPD7699 Phase 2
0.7135 Intermediate Similarity NPD7700 Phase 2
0.7134 Intermediate Similarity NPD9269 Phase 2
0.7126 Intermediate Similarity NPD6386 Approved
0.7126 Intermediate Similarity NPD6385 Approved
0.7107 Intermediate Similarity NPD1470 Approved
0.7107 Intermediate Similarity NPD3267 Approved
0.7107 Intermediate Similarity NPD3266 Approved
0.7099 Intermediate Similarity NPD411 Approved
0.7098 Intermediate Similarity NPD8285 Discontinued
0.7097 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.7097 Intermediate Similarity NPD9268 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data